Sanofi-aventis recherche & développement (SARD)

D. Bazile

Dr. Didier BazileSanofi logo

Sanofi will provide the peptides and will evaluate in-vivo several oral formulations containing these peptides. Efficacy will be assessed in the chronic constriction injury model compared to clinical reference drugs. Sanofi will also conduct pharmacokinetics studies and exploratory safety evaluation of the loaded nanocarriers.
[go to website]

Map-Europe-SARD UCC Roche SARD Serocience IOV UU MHH UA SIGMOID VN UCL UCL UCD USC IRB CEA